Hepatobiliary system-liver and pancreas and gall bladder and ducts, via natural or artificial opening

85813100 Category Share

Hepatobiliary system-liver and pancreas and gall bladder and ducts, via natural or artificial opening is an EFRIS commodity class (code 85813100) under Administrative interventions or procedures, physiological systems and anatomical regions, introduction and irrigation and circulatory in Uganda Revenue Authority's e-invoicing system.

34 items in this category

• 85813122Introduction of analgesics, hypnotics, sedatives into biliary and pancreatic tract, via natural or artificial opening
  Exempt
• 85813105Introduction of analgesics, hypnotics, sedatives into biliary and pancreatic tract, via natural or artificial opening endoscopic
  Exempt
• 85813129Introduction of anti-inflammatory into biliary and pancreatic tract, via natural or artificial opening
  Exempt
• 85813112Introduction of anti-inflammatory into biliary and pancreatic tract, via natural or artificial opening endoscopic
  Exempt
• 85813119Introduction of autologous pancreatic islet cells into biliary and pancreatic tract, via natural or artificial opening
  Exempt
• 85813102Introduction of autologous pancreatic islet cells into biliary and pancreatic tract, via natural or artificial opening endoscopic
  Exempt
• 85813120Introduction of destructive agent into biliary and pancreatic tract, via natural or artificial opening
  Exempt
• 85813103Introduction of destructive agent into biliary and pancreatic tract, via natural or artificial opening endoscopic
  Exempt
• 85813127Introduction of electrolytic and water balance substance into biliary and pancreatic tract, via natural or artificial opening
  Exempt
• 85813110Introduction of electrolytic and water balance substance into biliary and pancreatic tract, via natural or artificial opening endoscopic
  Exempt
• 85813134Introduction of liquid brachytherapy radioisotope into biliary and pancreatic tract, via natural or artificial opening
  Exempt
• 85813117Introduction of liquid brachytherapy radioisotope into biliary and pancreatic tract, via natural or artificial opening endoscopic
  Exempt
• 85813126Introduction of local anesthetic into biliary and pancreatic tract, via natural or artificial opening
  Exempt
• 85813109Introduction of local anesthetic into biliary and pancreatic tract, via natural or artificial opening endoscopic
  Exempt
• 85813132Introduction of monoclonal antibody into biliary and pancreatic tract, via natural or artificial opening
  Exempt
• 85813115Introduction of monoclonal antibody into biliary and pancreatic tract, via natural or artificial opening endoscopic
  Exempt
• 85813118Introduction of nonautologous pancreatic islet cells into biliary and pancreatic tract, via natural or artificial opening
  Exempt
• 85813101Introduction of nonautologous pancreatic islet cells into biliary and pancreatic tract, via natural or artificial opening endoscopic
  Exempt
• 85813128Introduction of nutritional substance into biliary and pancreatic tract, via natural or artificial opening
  Exempt
• 85813111Introduction of nutritional substance into biliary and pancreatic tract, via natural or artificial opening endoscopic
  Exempt
• 85813130Introduction of other anti-infective into biliary and pancreatic tract, via natural or artificial opening
  Exempt
• 85813113Introduction of other anti-infective into biliary and pancreatic tract, via natural or artificial opening endoscopic
  Exempt
• 85813133Introduction of other antineoplastic into biliary and pancreatic tract, via natural or artificial opening
  Exempt
• 85813116Introduction of other antineoplastic into biliary and pancreatic tract, via natural or artificial opening endoscopic
  Exempt
• 85813123Introduction of other diagnostic substance into biliary and pancreatic tract, via natural or artificial opening
  Exempt
• 85813106Introduction of other diagnostic substance into biliary and pancreatic tract, via natural or artificial opening endoscopic
  Exempt
• 85813121Introduction of other gas into biliary and pancreatic tract, via natural or artificial opening
  Exempt
• 85813104Introduction of other gas into biliary and pancreatic tract, via natural or artificial opening endoscopic
  Exempt
• 85813125Introduction of other therapeutic substance into biliary and pancreatic tract, via natural or artificial opening
  Exempt
• 85813108Introduction of other therapeutic substance into biliary and pancreatic tract, via natural or artificial opening endoscopic
  Exempt
• 85813131Introduction of oxazolidinones into biliary and pancreatic tract, via natural or artificial opening
  Exempt
• 85813114Introduction of oxazolidinones into biliary and pancreatic tract, via natural or artificial opening endoscopic
  Exempt
• 85813124Introduction of radioactive substance into biliary and pancreatic tract, via natural or artificial opening
  Exempt
• 85813107Introduction of radioactive substance into biliary and pancreatic tract, via natural or artificial opening endoscopic
  Exempt